Hengrui Therapeutics Overview

  • Status
  • Private
  • Latest Deal Type
  • Corporate
  • Financing Rounds
  • 1

Hengrui Therapeutics General Information

Description

Operator of a biopharmaceutical company. The company is engaged in the development and commercialization of cancer therapies. Its therapeutic areas of focus are oncology and endocrinology, with multiple clinical-stage assets for oncology/immuno-oncology and diabetes/weight loss.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 506 Carnegie Center
  • Suite 102
  • Princeton, NJ 08540
  • United States
+1 (609) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hengrui Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hengrui Therapeutics‘s full profile, request access.

Request a free trial

Hengrui Therapeutics Executive Team (1)

Name Title Board Seat Contact Info
Adam Zong Ph.D President & Chief Executive Officer
To view Hengrui Therapeutics’s complete executive team members history, request access »

Hengrui Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Hengrui Therapeutics‘s full profile, request access.

Request a free trial